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"Closer to a Cure" 
D ermatology is undoubtedly the most visually ori-ented medic~ speci~ lty and l.la~ occasionally been associated wIth artistic depIctIons of cutaneous diseases. However, rarely has the pathos and cha l-lenge of devastating skin disorders been addressed 
more powerfully than in the extraordinary mural depicted on the 
cover of this issue of the JOI//1/ol. This mural, entitled "Do You 
See Me? . .. A Naming Close to Paradise," was created by the 
intemationally recognized artist J ean-Claude Gaugy expressly for 
the Dystrophic Epidermolysis Bullosa Research Association 
(D.E.D.R.A.) of America and is presented in celebration of its 15 
years of dedication on behalf of the families with epidermolysis 
bullosa (ED) . * 
Fifteen years ago, at the time of the founding of D.E.B.I .A. of 
America, ED was an obscure, poorly understood , and often misdi-
agnosed genodermatosis. In large part due to the diligent efForts of 
D.E.D.R.A., working together with other organizations within the 
Coalition of Patient Advocates for Skill Disease R esearch, ED has 
become a household name withi.n the cutaneous biology research 
community . Efforts to disclose the molecular mechanisms underly-
ing diff"erent subtypes of ED have also been strongly supported by 
the National Institute of Arthritis, Musculoskeletal, and Skin 
Diseases through establishment of the National ED Registry and by 
providing continued support for ED research. 
The recent progress of ED researchers has been spectacular, and 
now distinct mutations in all three major forms of EB have been 
disclosed. In the simplex form, a large number of mutations in basal 
keratins, KRT5 and KRT14, have been identified; in the junctional 
fonns, mutations have been disclosed in all three candidate genes, 
LAMA3, LAMB3, and LAMC2, encoding the subunit polypeptides 
of laminin 5; and in dystrophic EB, over 50 mutations have been 
reported in the type VII coll agen gene, COL7Al, in both the 
* Posters of this mural are available from the Dystrophic Epidermolys is 
Bullosa Research Association (D .E.n .R .A.) of America, 40 R ector Street, 
8th Floor, New York, NY 10006 (Tel. 212-693-66 10; Fax. 212-693-6698). 
All proceeds go to D.E.B.R.A., and are tax deductable to the extent 
allowed by law. 
dominantly and recessively inherited fonns of the disease. Repre-
sentative reports have been published in the March and Apt;] issues 
of this JOllm.ol. 
These discoveries have several implications in terms of classifi-
cation, diagnosis, and management of patients affected with En. 
Most directly, however, tlIC families are already immediately 
benefitting from this research ilirough clinical applications, such as 
DNA-based prenatal diagnosis dw·ing the first trimester of gesta-
tion, as illustrated by I:'\'VO papers appearing in tlus issue of the 
Jo,,,,,/.OI. One study reports successful prediction of the phenotype in 
fetuses at l;sk for recurrence of severe, recessive dystrophic ED, and 
similar approaches in the junctional fonn have been taken by other 
investigators as well. To date, over 20 DNA-based predictions have 
been made in EB families during the first trimester of gestation, as 
early as the tenth week, through chorionic villus sampling or early 
amniocentesis. It is predictable that this technology wiIJ largely 
replace the currently ava.ilable fetal skin biopsy that usually takes 
place around the eighteenth to twentieth week of gestation. 
However, the next step is the development of preimplantation 
diagnosis, which will entil·ely obviate the necessity for termi.nation 
of pregnancy, if tllat is considered as an option by tlle parents. 
Fina.lly, the understanding of the precise genetic lesions w~derlyi.ng 
the different forms ofEB provides tlle basis for the development of 
gene therapy approaches to reverse the phenotypic maJufestations 
of the diff"erent forms of ED. 
We salute the Dystrophic Epidennolysis Bull osa Research Asso-
ciation of Amel-ica and its sister organizations around the world for 
their dedicated work and diligent eff"orts to assist aff"ected families 
and to educate the public at large of tlle existence of skin diseases, 
such as ED. Joining forces, there is hope for the prevention of tlus 
devastating skin disease, and we are now, 15 yea.rs later, closer to a 
cure. 
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